JP2019531764A5 - - Google Patents

Download PDF

Info

Publication number
JP2019531764A5
JP2019531764A5 JP2019537049A JP2019537049A JP2019531764A5 JP 2019531764 A5 JP2019531764 A5 JP 2019531764A5 JP 2019537049 A JP2019537049 A JP 2019537049A JP 2019537049 A JP2019537049 A JP 2019537049A JP 2019531764 A5 JP2019531764 A5 JP 2019531764A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
set forth
binding domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019537049A
Other languages
English (en)
Japanese (ja)
Other versions
JP7224289B2 (ja
JP2019531764A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/052808 external-priority patent/WO2018057802A1/en
Publication of JP2019531764A publication Critical patent/JP2019531764A/ja
Publication of JP2019531764A5 publication Critical patent/JP2019531764A5/ja
Priority to JP2023016697A priority Critical patent/JP2023058573A/ja
Application granted granted Critical
Publication of JP7224289B2 publication Critical patent/JP7224289B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019537049A 2016-09-21 2017-09-21 Cd123結合タンパク質並びに関連する組成物及び方法 Active JP7224289B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023016697A JP2023058573A (ja) 2016-09-21 2023-02-07 Cd123結合タンパク質並びに関連する組成物及び方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662397736P 2016-09-21 2016-09-21
US62/397,736 2016-09-21
US201762466192P 2017-03-02 2017-03-02
US62/466,192 2017-03-02
PCT/US2017/052808 WO2018057802A1 (en) 2016-09-21 2017-09-21 Cd123 binding proteins and related compositions and methods

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023016697A Division JP2023058573A (ja) 2016-09-21 2023-02-07 Cd123結合タンパク質並びに関連する組成物及び方法

Publications (3)

Publication Number Publication Date
JP2019531764A JP2019531764A (ja) 2019-11-07
JP2019531764A5 true JP2019531764A5 (enExample) 2020-12-17
JP7224289B2 JP7224289B2 (ja) 2023-02-17

Family

ID=61690646

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019537049A Active JP7224289B2 (ja) 2016-09-21 2017-09-21 Cd123結合タンパク質並びに関連する組成物及び方法
JP2023016697A Pending JP2023058573A (ja) 2016-09-21 2023-02-07 Cd123結合タンパク質並びに関連する組成物及び方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023016697A Pending JP2023058573A (ja) 2016-09-21 2023-02-07 Cd123結合タンパク質並びに関連する組成物及び方法

Country Status (17)

Country Link
US (5) US11242400B2 (enExample)
EP (1) EP3515491A4 (enExample)
JP (2) JP7224289B2 (enExample)
KR (1) KR102559732B1 (enExample)
CN (1) CN109952112B (enExample)
AU (1) AU2017331256B2 (enExample)
BR (1) BR112019005333A2 (enExample)
CA (1) CA3037688A1 (enExample)
CO (1) CO2019003951A2 (enExample)
IL (1) IL265484B2 (enExample)
MX (2) MX2019003225A (enExample)
MY (1) MY194290A (enExample)
PH (1) PH12019500609B1 (enExample)
SG (1) SG10202102846SA (enExample)
UA (1) UA127450C2 (enExample)
WO (1) WO2018057802A1 (enExample)
ZA (1) ZA201902323B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108367069B (zh) 2015-12-14 2022-08-23 宏观基因有限公司 对于pd-1和ctla-4具有免疫反应性的双特异性分子及其使用方法
EP3515491A4 (en) 2016-09-21 2020-09-16 Aptevo Research and Development LLC CD123 BINDING PROTEINS AND RELATED COMPOSITIONS AND PROCESSES
CN114040926B (zh) 2019-05-04 2025-07-29 印希比生物科学有限公司 结合cd123的多肽及其用途
EP3753954A1 (en) * 2019-06-21 2020-12-23 Université de Franche-Comté Anti-cd123 antibodies, anti-cd123 chimeric antigen receptors and anti-cd123 chimeric antigen receptors t cells
MX2022001882A (es) * 2019-08-12 2022-05-30 Aptevo Res & Development Llc Proteinas de union a 4-1bb y ox40 y composiciones y metodos relacionados anticuerpos contra 4-1bb, anticuerpos contra ox40.
CN110804096B (zh) * 2019-11-21 2021-07-06 深圳普瑞金生物药业有限公司 Cd123单域抗体、核苷酸序列、表达载体及试剂盒
US20230151102A1 (en) * 2020-01-13 2023-05-18 Aptevo Research And Development Llc Methods and compositions for preventing adsorption of therapeutic proteins to drug delivery system components
CN115279406A (zh) * 2020-01-13 2022-11-01 阿帕特夫研究和发展有限公司 蛋白质治疗剂的调配物
CN111171155B (zh) 2020-02-05 2021-02-19 北京智仁美博生物科技有限公司 抗cd3和cd123双特异性抗体及其用途
CN111732635B (zh) * 2020-06-22 2022-03-22 中国医学科学院基础医学研究所 与cd123蛋白特异性结合的多肽、多肽复合物、共递送系统及其制备方法与应用
US20230391856A1 (en) * 2020-10-23 2023-12-07 Icahn School Of Medicine At Mount Sinai Sars-cov-2 antibodies and uses thereof
AU2021390501A1 (en) * 2020-12-01 2023-06-29 Aptevo Research And Development Llc Heterodimeric psma and cd3-binding bispecific antibodies
CN117255807A (zh) * 2020-12-31 2023-12-19 赛诺菲 与NKp46和CD123结合的多功能自然杀伤(NK)细胞接合器
EP4294829A4 (en) * 2021-02-17 2025-03-19 IGM Biosciences Inc. ANTI-CD123 BINDING MOLECULES AND THEIR USES
US20240262920A1 (en) * 2021-05-21 2024-08-08 Aptevo Research And Development Llc Dosing regimens for protein therapeutics
CN116162148B (zh) * 2021-11-24 2025-09-09 中山光度生物医药有限公司 多特异性配体结合分子及其应用
CN116836282B (zh) * 2023-02-13 2024-03-29 北京艺妙神州医药科技有限公司 抗体、嵌合抗原受体及其用途
CN117660325B (zh) * 2024-01-31 2024-04-19 苏州科为康生物医药科技有限公司 一种制备脐带血msc的培养基及其方法

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
EP0590058B1 (en) 1991-06-14 2003-11-26 Genentech, Inc. HUMANIZED Heregulin ANTIBODy
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US5834597A (en) * 1996-05-20 1998-11-10 Protein Design Labs, Inc. Mutated nonactivating IgG2 domains and anti CD3 antibodies incorporating the same
EP0826696B1 (de) 1996-09-03 2002-05-29 GSF-Forschungszentrum für Umwelt und Gesundheit GmbH Verwendung bi-und trispezifischer Antikörper zur Induktion einer Tumorimmunität
AU2002329647A1 (en) 2001-07-26 2003-02-24 University Of Utah Research Foundation In vitro assays for inhibitors of hiv capsid conformational changes and for hiv capsid formation
CN102093477B (zh) 2002-05-22 2014-02-26 艾斯巴技术-诺华有限责任公司 在胞内环境中表现出增强的稳定性的免疫球蛋白构架及其鉴定方法
US7700097B2 (en) 2003-06-27 2010-04-20 Biogen Idec Ma Inc. Purification and preferential synthesis of binding molecules
EP1711527A4 (en) * 2003-12-15 2008-09-03 Dendreon Corp HLA-DR SPECIFIC ANTIBODIES, COMPOSITIONS AND METHODS
AU2006210660B2 (en) 2005-02-01 2011-12-01 Morphosys Ag Libraries and methods for isolating antibodies
JP2008539785A (ja) * 2005-05-16 2008-11-20 モルフォテック、インク. 所望の表現型を示す細胞を選択するために制御されたベクター
US8663634B2 (en) 2005-07-11 2014-03-04 Macrogenics, Inc. Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity
US7612181B2 (en) 2005-08-19 2009-11-03 Abbott Laboratories Dual variable domain immunoglobulin and uses thereof
CN105837690A (zh) 2006-06-12 2016-08-10 新兴产品开发西雅图有限公司 具有效应功能的单链多价结合蛋白
US7949480B2 (en) 2006-06-14 2011-05-24 Simphotek, Inc. Method for determining an interaction between an electromagnetic radiation and a material
HRP20160082T1 (hr) * 2006-09-29 2016-02-26 Oncomed Pharmaceuticals, Inc. Sastavi i postupci za dijagnosticiranje i lijeäśenje raka
US9364557B2 (en) 2007-08-01 2016-06-14 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Fold-back diabody diphtheria toxin immunotoxin and methods of use
MX2011003502A (es) * 2008-10-01 2011-09-01 Micromet Ag Anticuerpo de cadena sencilla biespecifica de psmaxcd3 especifico a traves de especies.
ES2550639T3 (es) * 2009-04-27 2015-11-11 Kyowa Hakko Kirin Co., Ltd. Anticuerpo anti-IL-3Ralfa para su utilización en el tratamiento de un tumor de la sangre
SI2477648T1 (sl) 2009-09-15 2022-09-30 The Board Of Trustees Of The Leland Stanford Junior University Sinergijska terapija proti CD47 za krvne rake
US20130089554A1 (en) 2009-12-29 2013-04-11 Emergent Product Development Seattle, Llc RON Binding Constructs and Methods of Use Thereof
NZ604510A (en) 2010-08-17 2013-10-25 Csl Ltd Dilutable biocidal compositions and methods of use
UA112062C2 (uk) 2010-10-04 2016-07-25 Бьорінгер Інгельхайм Інтернаціональ Гмбх Cd33-зв'язувальний агент
WO2012065161A2 (en) 2010-11-12 2012-05-18 Scott & White Healthcare Antibodies to tumor endothelial marker 8
IN2014MN02293A (enExample) * 2012-04-20 2015-08-07 Emergent Product Dev Seattle
EP2850106B1 (en) * 2012-05-18 2022-03-23 Aptevo Research and Development LLC Bispecific scfv immunofusion (bif) binding to cd123 and cd3
WO2014143807A2 (en) 2013-03-15 2014-09-18 Stromatt Scott Anti-cd37 antibody and bcr pathway antagonist combination therapy for treatment of b-cell malignancies and disorders
EP2839842A1 (en) * 2013-08-23 2015-02-25 MacroGenics, Inc. Bi-specific monovalent diabodies that are capable of binding CD123 and CD3 and uses thereof
DK3189081T3 (da) * 2014-09-05 2020-05-04 Janssen Pharmaceutica Nv Cd123-bindende midler og anvendelser deraf
US10259887B2 (en) * 2014-11-26 2019-04-16 Xencor, Inc. Heterodimeric antibodies that bind CD3 and tumor antigens
WO2016094873A2 (en) * 2014-12-12 2016-06-16 Emergent Product Development Seattle, Llc Receptor tyrosine kinase-like orphan receptor 1 binding proteins and related compositions and methods
TWI701258B (zh) * 2014-12-19 2020-08-11 美商再生元醫藥公司 流行性感冒病毒血球凝集素之人類抗體
AR103488A1 (es) * 2015-01-23 2017-05-10 Sanofi Sa Anticuerpos anti-cd3, anticuerpos anti-cd123 y anticuerpos biespecíficos que se unen específicamente a cd3 y/o cd123
US20180022819A1 (en) * 2015-02-11 2018-01-25 Aptevo Research And Development Llc Compositions and methods for combination therapy with prostate-specific membrane antigen binding proteins
HK1251480A1 (zh) * 2015-09-21 2019-02-01 Aptevo Research And Development Llc Cd3结合多肽
EP3464365A1 (en) 2016-06-01 2019-04-10 Xencor, Inc. Bispecific antibodies that bind cd123 and cd3
EP3515491A4 (en) * 2016-09-21 2020-09-16 Aptevo Research and Development LLC CD123 BINDING PROTEINS AND RELATED COMPOSITIONS AND PROCESSES
US20230151102A1 (en) 2020-01-13 2023-05-18 Aptevo Research And Development Llc Methods and compositions for preventing adsorption of therapeutic proteins to drug delivery system components
CN115279406A (zh) 2020-01-13 2022-11-01 阿帕特夫研究和发展有限公司 蛋白质治疗剂的调配物

Similar Documents

Publication Publication Date Title
JP2023058573A5 (enExample)
JP2021524244A5 (enExample)
JP2019110906A5 (enExample)
JP2021527431A5 (enExample)
JP2015533853A5 (enExample)
JP2018531000A5 (enExample)
IL276830B1 (en) Anti-claudin 18.2 antibodies and their uses
JP2016505556A5 (enExample)
JP2021514664A5 (enExample)
JP2020501531A5 (enExample)
JP2017149720A5 (enExample)
JP2018510617A5 (enExample)
JP2018519263A5 (enExample)
JP2017535257A5 (enExample)
JP2018503380A5 (enExample)
JP2017506067A5 (enExample)
HK1215035A1 (zh) 人源化抗cd134(ox40)抗體及其應用
JP2018521691A5 (enExample)
JP2016512223A5 (enExample)
JP2018513149A5 (enExample)
JP2020530770A5 (enExample)
RU2014106671A (ru) Варианты гуманизированных иммуномодулирующих моноклональных антител
JP2015535828A5 (enExample)
JP2013545738A5 (enExample)
IL258202B2 (en) CD3-binding polypeptides, a method for their preparation, pharmaceutical preparations, nucleic acids, vectors and the use of such polypeptides